BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10928383)

  • 1. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
    Boerman OC; Oyen WJ; Corstens FH
    Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of peptide-based radiopharmaceuticals.
    Dijkgraaf I; Boerman OC; Oyen WJ; Corstens FH; Gotthardt M
    Anticancer Agents Med Chem; 2007 Sep; 7(5):543-51. PubMed ID: 17896914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.
    Khan IU; Beck-Sickinger AG
    Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
    Sosabowsky J; Melendez-Alafort L; Mather S
    Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated cassette-based production of high specific activity [
    Li M; Zhang X; Quinn TP; Lee D; Liu D; Kunkel F; Zimmerman BE; McAlister D; Olewein K; Menda Y; Mirzadeh S; Copping R; Johnson FL; Schultz MK
    Appl Radiat Isot; 2017 Sep; 127():52-60. PubMed ID: 28521118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and perspectives in peptide receptor radiation therapy.
    Ansquer C; Kraeber-Bodéré F; Chatal JF
    Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
    Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-based radiopharmaceuticals for targeted tumor therapy.
    Dong C; Liu Z; Wang F
    Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
    Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiopeptide imaging and therapy in Europe.
    Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
    J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
    Weiner RE; Thakur ML
    Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidates for peptide receptor radiotherapy today and in the future.
    Reubi JC; Mäcke HR; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides for tumour therapy and diagnosis: current status and future directions.
    Zaccaro L; Del Gatto A; Pedone C; Saviano M
    Curr Med Chem; 2009; 16(7):780-95. PubMed ID: 19275595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
    Okarvi SM
    Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
    Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
    Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
    de Visser M; Verwijnen SM; de Jong M
    Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.